Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹24.84 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹24.84 Cr |
| Fresh Issue | ₹23.54 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹85.00-90.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543916 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Hem Securities Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Incorporated in 1989, Hemant Surgical Industries Limited is engaged in the business of manufacturing, importing, and assembling. Also, the company markets a comprehensive portfolio of medical equipments and disposables.
The wide spectrum of equipments and disposables offered by the company includes:
The products processed in the assembly units of the company are imported from countries like: Japan, China France, and Australia.
Hemant Surgical Industries presently has one manufacturing unit and two assembly units. The first Manufacturing Unit is situated at Achad Industrial Estate. The company started its operations of importing and marketing of medical disposables through this unit in 1999. The other two assembling units are located at Atgaon and Bhiwandi, respectively. These two assembling units undertake the assembling of medical products and devices.
The company's facilities are ISO 9001:2015 and ISO 13485:2016 certified. They have a fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line processes.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding Capital Expenditure towards installation of additional plant and machinery | 7.51 |
| 2 | Funding to meet working capital requirements | 10.00 |
| 3 | General Corporate Purpose | 3.14 |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 64.91 | 54.38 | 42.90 |
| Total Income | 111.50 | 105.77 | 60.65 |
| Profit After Tax | 7.65 | 4.61 | 1.15 |
| NET Worth | 23.60 | 12.98 | 8.37 |
| Reserves and Surplus | 15.92 | 11.15 | 6.53 |
| Total Borrowing | 7.12 | 9.74 | 14.46 |
| Amount in ₹ Crore | |||
| KPI | |
|---|---|
| ROE | 32.42% |
| ROCE | 37.98% |
| Debt / Equity | 0.30% |
| RoNW | 32.42% |
| PAT Margin | 7.01% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 10.26 | |
| P/E (x) | 12.28 | |
| Promoter Holding | 100.00% | 73.56% |
| Market Cap | ₹93.96 Cr. | |
